BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 8245449)

  • 1. CD28-mediated costimulation is necessary for the activation of T cell receptor-gamma delta+ T lymphocytes.
    Sperling AI; Linsley PS; Barrett TA; Bluestone JA
    J Immunol; 1993 Dec; 151(11):6043-50. PubMed ID: 8245449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR-gamma delta cells in CD3 zeta-deficient mice contain Fc epsilon RI gamma in the receptor complex but are specifically unresponsive to antigen.
    Khattri R; Sperling AI; Qian D; Fitch FW; Shores EW; Love PE; Bluestone JA
    J Immunol; 1996 Sep; 157(6):2320-7. PubMed ID: 8805629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody.
    Holsti MA; McArthur J; Allison JP; Raulet DH
    J Immunol; 1994 Feb; 152(4):1618-28. PubMed ID: 7907103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes.
    Tan R; Teh SJ; Ledbetter JA; Linsley PS; Teh HS
    J Immunol; 1992 Nov; 149(10):3217-24. PubMed ID: 1385518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactive gamma delta thymocytes utilize distinct costimulatory signals from peripheral T cells.
    Penninger JM; Timms E; Shahinian A; Jezo-Bremond A; Nishina H; Ionescu J; Hedrick SM; Mak TW
    J Immunol; 1995 Oct; 155(8):3847-55. PubMed ID: 7561091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRC OX-2 defines a novel T cell costimulatory pathway.
    Borriello F; Lederer J; Scott S; Sharpe AH
    J Immunol; 1997 May; 158(10):4548-54. PubMed ID: 9144466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines.
    Gilfillan MC; Noel PJ; Podack ER; Reiner SL; Thompson CB
    J Immunol; 1998 Mar; 160(5):2180-7. PubMed ID: 9498756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Linsley PS
    J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response.
    Dubey C; Croft M; Swain SL
    J Immunol; 1995 Jul; 155(1):45-57. PubMed ID: 7541426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reactive, T cell receptor-gamma delta+, lymphocytes from the intestinal epithelium of weanling mice.
    Nagler-Anderson C; McNair LA; Cradock A
    J Immunol; 1992 Oct; 149(7):2315-22. PubMed ID: 1382095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
    Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 costimulation is required not only to induce IL-12 receptor but also to render janus kinases/STAT4 responsive to IL-12 stimulation in TCR-triggered T cells.
    Park WR; Park CS; Tomura M; Ahn HJ; Nakahira Y; Iwasaki M; Gao P; Abe R; Hamaoka T; Fujiwara H
    Eur J Immunol; 2001 May; 31(5):1456-64. PubMed ID: 11465102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells.
    Jenkins MK; Taylor PS; Norton SD; Urdahl KB
    J Immunol; 1991 Oct; 147(8):2461-6. PubMed ID: 1717561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulation with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 augments activation-induced death of antigen-specific CD4+ T lymphocytes.
    Damle NK; Klussman K; Leytze G; Aruffo A; Linsley PS; Ledbetter JA
    J Immunol; 1993 Sep; 151(5):2368-79. PubMed ID: 7689606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD9-mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis.
    Tai XG; Toyooka K; Yashiro Y; Abe R; Park CS; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
    J Immunol; 1997 Oct; 159(8):3799-807. PubMed ID: 9378967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.